MACK DAVID J. bought BTAI
August 31, 2025 · Form 4 insider transaction
MACK DAVID J. bought 1,693 shares of BioXcel Therapeutics, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,693
Price
N/A
Total value
N/A
InsiderMACK DAVID J.
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 31, 2025
Filing dateSeptember 2, 2025
Shares owned after16,930
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.